Cargando…

Alternative Complement Pathway Inhibition Abrogates Pneumococcal Opsonophagocytosis in Vaccine-Naïve, but Not in Vaccinated Individuals

To assess the relative contribution of opsonisation by antibodies, classical and alternative complement pathways to pneumococcal phagocytosis, we analyzed killing of pneumococci by human blood leukocytes collected from vaccine-naïve and PCV13-vaccinated subjects. With serotype 4 pneumococci as model...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muri, Lukas, Ispasanie, Emma, Schubart, Anna, Thorburn, Christine, Zamurovic, Natasa, Holbro, Thomas, Kammüller, Michael, Pluschke, Gerd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543009/ https://www.ncbi.nlm.nih.gov/pubmed/34707606 http://dx.doi.org/10.3389/fimmu.2021.732146

Ejemplares similares

Alternative Complement Pathway Inhibition Does Not Abrogate Meningococcal Killing by Serum of Vaccinated Individuals
por: Ispasanie, Emma, et al.
Publicado: (2021)

Inhibition of the different complement pathways has varying impacts on the serum bactericidal activity and opsonophagocytosis against Haemophilus influenzae type b
por: Muri, Lukas, et al.
Publicado: (2022)

In vaccinated individuals serum bactericidal activity against B meningococci is abrogated by C5 inhibition but not by inhibition of the alternative complement pathway
por: Ispasanie, Emma, et al.
Publicado: (2023)

The role of specific antibody in alternative complement pathway- mediated opsonophagocytosis of type III, group B Streptococcus
Publicado: (1980)

Characterization of vaccine antigens of meningococcal serogroup W isolates from Ghana and Burkina Faso from 2003 to 2009
por: Ispasanie, Emma, et al.
Publicado: (2014)

2710. Novel Analytical Models for Pneumococcal Multiplex Opsonophagocytosis Assay Results from a Healthy Older Adult Population Vaccinated with PCV13
por: LaFon, David, et al.
Publicado: (2019)

The Protease SplB of Staphylococcus aureus Targets Host Complement Components and Inhibits Complement-Mediated Bacterial Opsonophagocytosis
por: Dasari, Prasad, et al.
Publicado: (2022)

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination
por: Bhorat, As’ad E., et al.
Publicado: (2015)

Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae
por: Thomas, Stephen R., et al.
Publicado: (2018)

Role of Opsonophagocytosis in Immune Protection against Malaria
por: Leitner, Wolfgang W., et al.
Publicado: (2020)

Immune Adherence–mediated Opsonophagocytosis: The Mechanism of Leishmania Infection
por: Domínguez, Mercedes, et al.
Publicado: (1999)

Low‐molecular weight inhibitors of the alternative complement pathway
por: Schubart, Anna, et al.
Publicado: (2022)

A Factor H-Fc fusion protein increases complement-mediated opsonophagocytosis and killing of community associated methicillin-resistant Staphylococcus aureus
por: Sage, Megan A. G., et al.
Publicado: (2022)

Community acquired paediatric pneumonia; experience from a pneumococcal vaccine- naive population
por: Kudagammana, Sanath Thushara, et al.
Publicado: (2020)

Delayed fractional dose regimen of the RTS,S/AS01 malaria vaccine candidate enhances an IgG4 response that inhibits serum opsonophagocytosis
por: Chaudhury, Sidhartha, et al.
Publicado: (2017)

Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction
por: Chen, Tingting, et al.
Publicado: (2016)

Carbamylation of immunoglobulin abrogates activation of the classical complement pathway
por: Koro, Catalin, et al.
Publicado: (2014)

Recent Topics of Pneumococcal Vaccination: Indication of Pneumococcal Vaccine for Individuals at a Risk of Pneumococcal Disease in Adults
por: Asai, Nobuhiro, et al.
Publicado: (2021)

Global Control of Pneumococcal Infections by Pneumococcal Vaccines
por: Oishi, Kazunori, et al.
Publicado: (2014)

Pneumococcal disease and use of pneumococcal vaccines in Taiwan
por: Wei, Sung-Hsi, et al.
Publicado: (2015)

Aspirin enhances opsonophagocytosis and is associated to a lower risk for Klebsiella pneumoniae invasive syndrome
por: Lee, Chen-Hsiang, et al.
Publicado: (2014)

Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination
por: van den Biggelaar, Anita H. J., et al.
Publicado: (2017)

Molecular epidemiology of pneumococci obtained from Gambian children aged 2–29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine
por: Antonio, Martin, et al.
Publicado: (2008)

Mycobacterium ulcerans Mouse Model Refinement for Pre-Clinical Profiling of Vaccine Candidates
por: Bénard, Angèle, et al.
Publicado: (2016)

Decrease in Pneumococcal Co-Colonization following Vaccination with the Seven-Valent Pneumococcal Conjugate Vaccine
por: Valente, Carina, et al.
Publicado: (2012)

Effect of Age and Vaccination With a Pneumococcal Conjugate Vaccine on the Density of Pneumococcal Nasopharyngeal Carriage
por: Roca, A., et al.
Publicado: (2012)

Pneumococcal Conjugate Vaccination Followed by Pneumococcal Polysaccharide Vaccination in Lung Transplant Candidates and Recipients
por: Hoffman, Thijs W., et al.
Publicado: (2020)

Multi-Serotype Pneumococcal Nasopharyngeal Carriage Prevalence in Vaccine Naïve Nepalese Children, Assessed Using Molecular Serotyping
por: Kandasamy, Rama, et al.
Publicado: (2015)

Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations
por: Naucler, Pontus, et al.
Publicado: (2017)

Development of A Standardized Opsonophagocytosis Killing Assay for Group B Streptococcus and Assessment in an Interlaboratory Study
por: Leung, Stephanie, et al.
Publicado: (2023)

Pneumococcal Vaccines: Challenges and Prospects
por: Licciardi, Paul, et al.
Publicado: (2019)

Pneumococcal vaccine schedules (PVS) study: a cluster-randomised, non-inferiority trial of an alternative versus standard schedule for pneumococcal conjugate vaccination—statistical analysis plan
por: Mackenzie, Grant A., et al.
Publicado: (2022)

Outpatient-Based Pneumococcal Vaccine Campaign and Survey of Perceptions about Pneumococcal Vaccination in Patients and Doctors
por: Song, Joon Young, et al.
Publicado: (2013)

A Synthetic Virus-Like Particle Streptococcal Vaccine Candidate Using B-Cell Epitopes from the Proline-Rich Region of Pneumococcal Surface Protein A
por: Tamborrini, Marco, et al.
Publicado: (2015)

Vector Transmission of Leishmania Abrogates Vaccine-Induced Protective Immunity
por: Peters, Nathan C., et al.
Publicado: (2009)

Streptococcus pneumoniae colonization in pneumococcal vaccine-naïve human immunodeficiency virus-exposed infected and -uninfected South African children
por: Nunes, Marta Coelho, et al.
Publicado: (2020)

Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease
por: Bolz, Miriam, et al.
Publicado: (2015)

Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2019)

Changes in the Pneumococcal Vaccine Serotypes in Adult Noninvasive Pneumonia after the Introduction of Pneumococcal Conjugate Vaccination for Children
por: Takeda, Hiroaki, et al.
Publicado: (2019)

Pneumococcal vaccine/rituximab: Acquired humoral deficiency leading to infections and pneumococcal vaccine failure: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p4gmr2igstdel1kan0ottt2inl